UOC
ACAD icon

UBS O'Connor’s Acadia Pharmaceuticals ACAD Stock Holding History

UBS O'Connor’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-43,000
Closed -$928K – 278
2025
Q2 		$928K Buy
+43,000
New +$799K 0.03% 227
2016
Q2 		– Sell
-11,096
Closed -$310K – 398
2016
Q1 		$310K Buy
+11,096
New +$242K 0.01% 383
2014
Q2 		– Sell
-30,000
Closed -$730K – 433
2014
Q1 		$730K Buy
+30,000
New +$759K 0.01% 339
2013
Q4 		– Hold
0
– – – 402

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return